Clear.bio
Startup that measures blood glucose levels in real-time using a chip-implanted arm patch and an app
Clear.bio has raised €1.7M across 2 funding rounds from 5 investors, most recently a round in Sep 2025. Based in Amsterdam, Netherlands; active in Healthtech. Data as of 28 Oct 2026.
Amsterdam, Netherlandswww.clear.bio ↗
Total raised
€1.7M
€1,700,000
Funding rounds
2
Investors
5
distinct backers
Active since
2022-11
latest 2025-09
Funding by year
EUR raised per yearClear.bio — funding by year — interactive chart.
Data table
| Clear.bio — funding by year | |
|---|---|
| 2022 | €0 |
| 2025 | €1.7M |
Signals
Medium confidenceRaise-next likelihood42
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Exit likelihood12
base rate 11% (2+ rounds)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-29 | Other | €1.7M | Business Angels,Horizon Flevoland,Invest International’s Dutch Trade & Investment Fund,The Future Food Fund | View deal → |
| 2022-11-18 | Other | — | Achmea Innovation Fund | View deal → |
Investors
5Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData